New Hernia Repair Products At 2009 Abdominal Wall Reconstruction Conference
Covidien (NYSE: COV), a leading global provider of healthcare products, will exhibit a number of innovative devices for state-of-the-art hernia repair at Georgetown University Hospital’s Abdominal Wall Reconstruction (AWR) conference in Washington, DC on June 25-27, 2009. Hernia repair is one of the most performed surgical procedures worldwide.
Featured at booth #16, Covidien’s advanced mesh products are the result of close collaboration with surgeons seeking a more effective approach to soft tissue repair. These devices, which are part of Covidien’s comprehensive line of hernia repair solutions, include:
Permacol™ Biologic Implant – a biologic mesh for hernia and abdominal wall repair that combines the clinical advantages of a biologic with the durability, strength and size of a synthetic in an acellular porcine dermal implant. The implant utilizes a unique crosslinking formula that adds to the durability of the repair while providing the bioavailability expected of a biologic implant. Further information can be downloaded at covidien.com/hernia.
Parietex™ Composite (PCO) Mesh – a synthetic mesh of three dimensional weave that allows for optimal tissue ingrowth and patient comfort for hernia and abdominal wall repair. The absorbable collagen film is designed to provide protection from tissue attachments when necessary, but is absorbed after the peritoneum has healed and the extra protection is no longer needed, leaving less foreign material in the body. Additional information is available at covidien.com/syneture.
AbsorbaTack™ 5mm Fixation Device – an absorbable tacker that combines reliable fixation strength and biocompatible absorbability for mesh security in hernia repair. Millions of AbsorbaTack tacks have been sold since the device’s launch, providing surgeons with a track record they can trust. With both 20-tack and 10-tack configurations, AbsorbaTack is designed for both laparoscopic ventral hernia and laparoscopic inguinal repair. For more information, please visit absorbatack.com.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.